close
MENU
Hot Topic Reporting season
Hot Topic Reporting season
Tech & Innovation
6 mins to read

Helius expects medicinal cannabis sales to near double this year

The medicinal cannabis company is gearing up to export.

Helius CEO Carmen Doran speaks with Fiona Rotherham.

Helius Therapeutics, the country’s largest licensed medical cannabis producer, expects industry-wide sales will nearly double this year based on 2022 growth rates.

Helius chief executive Carmen Doran – who is also a member of the industry body, the NZ Medical Cannabis Council – said she was

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace
NZ Aviation News

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Aviation News - Monthly

NZ$14.95 / monthly

Already have an account? Login
Fiona Rotherham Mon, 13 Feb 2023
Contact the Writer: fiona@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Helius expects medicinal cannabis sales to near double this year
Tech & Innovation,
97619
true